Form D · Biotechnology
Aionx Antimicrobial Technologies, Inc.
Hershey, PA · CIK 0001491977
Offering snapshot reported Jul 22, 2022 · SEC filing
- Reported sold
- $101K Offering amount: $2.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 8, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 22, 2022 | Initial | $101,157 | No comparison | 5 | SEC filing |
| Mar 3, 2022 | Amendment | $1,130,000 | $430,000vs Feb 26, 2021 | 17 | SEC filing |
| Feb 26, 2021 | Amendment | $700,000 | $325,000vs Feb 26, 2020 | 10 | SEC filing |
| Feb 26, 2020 | Initial | $375,000 | No comparison | 5 | SEC filing |
| Feb 19, 2019 | Amendment | $3,845,545 | $871,912vs Feb 22, 2018 | 25 | SEC filing |
| Feb 22, 2018 | Initial | $2,973,633 | No comparison | 16 | SEC filing |
| Jun 20, 2014 | Initial | $494,908 | No comparison | 13 | SEC filing |
| Sep 26, 2011 | Initial | $500,184 | No comparison | 11 | SEC filing |
| May 14, 2010 | Initial | $250,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-453332
Source: Form D, filed Jul 22, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gregory M. Bailey | Director |
| Timothy Breya | Executive |
| Paul H. Cohen | Director |
| Thomas A. Fuller | Promoter |
| James Hart | Director |
| Terry J. Margolis | Director |
| Ryan J. Mc Combie | Director |
| Gautam Patel | Director |
| Wayne J. Sebastianelli | Director |
| Gary J. Shope | Director, Executive, Promoter |
| Robert C. Voigt | Director |
| Richard A. Wysk | Director |
| Seth R. Zimmerman | Executive |
| Jon C. Zimmerman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
515 Rear West Chocolate Avenue
Hershey, PA, 17033
Hershey, PA, 17033